Concentra Group Holdings Parent, Inc. Announces Results for Its First Quarter Ended March 31, 2026, Cash Dividend, and Raised FY 2026 Guidance
Concentra reported Q1 2026 revenue of $569.6 million, up 13.7% year-over-year, with net income rising 28.7% to $52.3 million. Adjusted EBITDA reached $120.7 million, a 17.6% increase from $102.7 million in Q1 2025, while Free Cash Flow turned positive at $9.9 million. The company raised its full-year 2026 guidance, now expecting revenue between $2.275 billion and $2.375 billion, with Adjusted EBITDA of $460 million to $480 million and Free Cash Flow of $215 million to $235 million.
Key figures
- Eps
- 0.39
- Eps Beat
- 0.1
- Revenue
- 569600000
- Guidance
- FY2026 revenue $2.275B-$2.375B, Adjusted EBITDA $460M-$480M, Free Cash Flow $215M-$235M
- Revenue Yoy
- 13.7%
- Deal Value Usd
- 0
- Offering Price
- 0
- Shares Offered
- 0
- Free cash flow
- 99000000
- Patient visits
- 3419091
- Adjusted ebitda
- 120700000
- Revenue per visit
- 151.47
- Free cash flow yoy
- 12.7%
- Patient visits yoy
- 6.7%
- Adjusted ebitda yoy
- 17.6%
- Onsite health clinics
- 411
- Revenue per visit yoy
- 3.1%
- Occupational health centers
- 632
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.